Immunobiology of allogeneic hematopoietic stem cell transplantation

Lisbeth A. Welniak, Bruce R. Blazar, William J Murphy

Research output: Contribution to journalArticle

332 Scopus citations

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host. Much of the immunobiology of allogeneic HSCT has been gleaned from preclinical models and correlation with clinical observations. We review our current understanding of some of the issues that affect the success of this therapy, including host-versus-graft (HVG) reactions, graft-versus-host disease (GVHD), graft-versus-tumor (GVT) activity, and restoration of functional immunity to prevent transplant-related opportunistic infections. We also review new strategies to optimize the GVT and improve overall immune function while reducing GVHD and graft rejection.

Original languageEnglish (US)
Pages (from-to)139-170
Number of pages32
JournalAnnual Review of Immunology
Volume25
DOIs
StatePublished - 2007
Externally publishedYes

    Fingerprint

Keywords

  • Graft rejection
  • Graft-versus-host disease
  • Immune reconstitution

ASJC Scopus subject areas

  • Immunology

Cite this